2-(4-(Bromomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97.0%, 5g

1,5-Dioctadecyl N-(3-carboxy-1-oxopropyl)-L-glutamate, 98%, 250mg

7-Benzyloxy-4-chloro-6-methoxyquinoline, 95.0%, 25g

3,5-Difluorobenzeneboronic acid, 98.0%, 500g

4-Chlorobut-2-yn-1-ol, 98%, 10g

Tri-m-cresyl Phosphate>95.0%(GC)5g

1H-INDOLE-1-CARBOXYLIC ACID, 5-(BROMOMETHYL)-, 1,1-DIMETHYLETHYL ESTER, 95%, 500mg

3-Iodo-5-methoxy-1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine, 98+%, 250mg

Reaktionsgefäß, DN100, 0,25 l, zylindr.,, gradu., Temp.-Vak.-Mantel, Entleerungsventil., 1 Stück

1,6,7,8,9,9a-hexahydropyrazino[2,1-c][1,4]oxazin-4-one hydrochloride, 500mg

1-(1-ethyl-1H-imidazol-2-yl)piperazine dihydrochloride, 95.0%, 500mg

3-(4-Fluorophenyl)oxetan-3-ol, 98%, 500mg

p-(1-Adamantyl)toluene>95.0%(GC)5g